Proteolysis of a histone acetyl reader, ATAD2, induces chemoresistance of cancer cells under severe hypoxia by inhibiting cell cycle progression in S phase.
ATAD2
Cell cycle retardation
Chemoresistance
Proteolysis
Tumor hypoxia
Journal
Cancer letters
ISSN: 1872-7980
Titre abrégé: Cancer Lett
Pays: Ireland
ID NLM: 7600053
Informations de publication
Date de publication:
01 03 2022
01 03 2022
Historique:
received:
19
04
2021
revised:
01
12
2021
accepted:
26
12
2021
pubmed:
2
1
2022
medline:
16
2
2022
entrez:
1
1
2022
Statut:
ppublish
Résumé
Cancer cells acquire chemoresistance in hypoxic regions of solid tumors, which is suggested to be at least partly due to reduction of their proliferative activity. However, molecular mechanisms behind it have not been fully elucidated. Here, we revealed the importance of active proteolysis of a histone acetylation reader, ATPase family AAA domain containing 2 (ATAD2), under hypoxia. We found that inactivation of an O
Identifiants
pubmed: 34973392
pii: S0304-3835(21)00645-5
doi: 10.1016/j.canlet.2021.12.028
pii:
doi:
Substances chimiques
DNA-Binding Proteins
0
Histones
0
ATAD2 protein, human
EC 3.6.1.3
ATPases Associated with Diverse Cellular Activities
EC 3.6.4.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
76-84Informations de copyright
Copyright © 2022 Elsevier B.V. All rights reserved.